ID: ALA3980243

Max Phase: Preclinical

Molecular Formula: C15H10ClN3O2

Molecular Weight: 299.72

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1cccc(Cl)c1)[n+]1nn([O-])c2ccccc21

Standard InChI:  InChI=1S/C15H10ClN3O2/c16-12-5-3-4-11(10-12)8-9-15(20)18-13-6-1-2-7-14(13)19(21)17-18/h1-10H/b9-8+

Standard InChI Key:  AOFZAIKOPGVTOF-CMDGGOBGSA-N

Associated Targets(non-human)

Protein-glutamine gamma-glutamyltransferase 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 299.72Molecular Weight (Monoisotopic): 299.0462AlogP: 2.68#Rotatable Bonds: 2
Polar Surface Area: 61.83Molecular Species: ACIDHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.80CX Basic pKa: CX LogP: 0.50CX LogD: -0.55
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.54Np Likeness Score: -0.54

References

1.  (2015)  Cinnamoyl inhibitors of transglutaminase, 

Source

Source(1):